Mark G. Ward
Impact in
- Genetics top 5%
- Inflammatory Bowel Disease
-
- Biosimilars and Bioanalytical Methods
- Immunodeficiency and Autoimmune Disorders
Papers in
- Genetics 31
- Inflammatory Bowel Disease 31
- Chronic Lymphocytic Leukemia Research 4
- Epidemiology 24
- Microscopic Colitis 23
- Co-authors
- Miles Sparrow (18 shared papers)Xavier Roblin (4 shared papers)Peter M. Irving (16 shared papers)Peter R. Gibson (10 shared papers)Jeremy Sanderson (10 shared papers)Klaus Geißler (1 shared paper)P. Mayer (1 shared paper)D Metcalf (1 shared paper)
- Journals
- Gastroenterology (7 papers)Alimentary Pharmacology & Therapeutics (4 papers)Journal of Gastroenterology and Hepatology (4 papers)Gut (4 papers)Inflammatory Bowel Diseases (4 papers)
- Partner nations
- AustraliaUnited KingdomFrance
In The Last Decade
Mark G. Ward
43 papers receiving 540 citations
Peers
Comparison fields: 5 of 76
- Genetics 369
- Immunology 199
- Epidemiology 255
- Gastroenterology 30
- Hematology 38
Countries citing papers authored by Mark G. Ward
This map shows the geographic impact of Mark G. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Ward more than expected).
Fields of papers citing papers by Mark G. Ward
This network shows the impact of papers produced by Mark G. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Ward. The network helps show where Mark G. Ward may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark G. Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 61 | |
| 2 | 1993 | 53 | |
| 3 | 2017 | 51 | |
| 4 | 2018 | 43 | |
| 5 | 2015 | 43 | |
| 6 | 2020 | 40 | |
| 7 | 2017 | 30 | |
| 8 | 2022 | 24 | |
| 9 | 2016 | 23 | |
| 10 | 2017 | 18 | |
| 11 | 1975 | 16 | |
| 12 | 2017 | 15 | |
| 13 | 2024 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 13 | |
| 17 | 2020 | 10 | |
| 18 | 2021 | 8 | |
| 19 | 2024 | 8 | |
| 20 | 2009 | 8 |
About Mark G. Ward
Mark G. Ward is a scholar working on Genetics, Epidemiology, Immunology, Public Health, Environmental and Occupational Health and Surgery, having authored 45 papers that have together received 553 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (31 papers), Microscopic Colitis (23 papers), Acute Lymphoblastic Leukemia research (9 papers), Biosimilars and Bioanalytical Methods (8 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Pregnancy and Medication Impact (4 papers) and Eosinophilic Esophagitis (4 papers). The work is most often cited by research in Genetics (369 citations), Immunology (199 citations), Epidemiology (255 citations), Gastroenterology (30 citations) and Hematology (38 citations). Mark G. Ward has collaborated with scholars based in Australia, United Kingdom and France. Frequent co-authors include Miles Sparrow, Xavier Roblin, Peter M. Irving, Peter R. Gibson, Jeremy Sanderson, Klaus Geißler, P. Mayer, D Metcalf, Kirstin M. Taylor and Viraj C. Kariyawasam. Their work appears in journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics, Journal of Gastroenterology and Hepatology, Gut and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.